Johnson M A, Lee S K, Park J H. "Method for the Synthesis of Methyl (3,5-diamino-6-chloropyrazine-2-carbonyl)carbamimidothioate" [P]. US Patent, US 11446697 B2, 2022-04-19.
发明人黄志刚,陈志强,刘建华. "A Process for Preparing High-Purity Methyl (3,5-diamino-6-chloropyrazine-2-carbonyl)carbamimidothioate" [P]. 中国发明专利, 专利号 CN 114249075 B, 授权公告日 2015-01-28.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2019, 1067, (3), 476-480.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2021, 1737, (2), 1189-1218.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Methyl (3,5-diamino-6-chloropyrazine-2-carbonyl)carbamimidothioate Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 645, (9), 6222-6230.